Deep Science Ventures

Dunia Innovations is pioneering the development of the world's first self-driving laboratory dedicated to electrocatalytic CO2 utilization. The company aims to facilitate the energy transition by addressing challenges in scalable carbon utilization, thereby fostering a circular carbon economy. By transforming carbon dioxide into valuable chemicals and fuels, Dunia Innovations helps businesses understand their carbon footprints and actively contributes to achieving net zero emissions. Through its innovative approach, the company seeks to significantly accelerate catalyst research and optimize processes for effective carbon management.

Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

Bastion Therapeutics is a preclinical biotechnology company developing proprietary platform technology to enhance regulatory T cells (Tregs) for immune system modulation.

Xonai is a software development company that specializes in accelerated computing for data processing platforms. It has developed a fully automated hardware selection and data management platform aimed at creating a universal and flexible infrastructure for cloud computing. Xonai's technology focuses on optimizing data infrastructure to enhance the efficiency of data software, thereby reducing cloud expenses. This enables organizations to scale their data and AI-driven products more effectively, ultimately accelerating their time to value while minimizing costs.

Antiverse is an innovative biotechnology company specializing in accelerating drug development through its proprietary platform. This platform combines structural biology, machine learning, and medicine to facilitate quicker and more cost-effective breakthroughs in antibody discovery.

Rhizocore Technologies specializes in producing locally-adapted mycorrhizal fungi to enhance tree planting success. Its platform aims to boost woodland restoration, commercial productivity, and environmental stress tolerance within the forestry market.

Holy Grail develops an air carbon capture device designed to capture carbon dioxide from large centralized emitters and the atmosphere, with the captured CO2 permanently stored above ground. The device uses an electrochemical approach that employs electrons to facilitate carbon capture. The company engages in research and development and engineering of products such as batteries, catalysts, and material datasets that can be used to cross-validate predictions and simulations of experimental data. This technology is positioned to help industrial clients improve energy efficiency and economics by reducing emissions and enabling practical carbon management.

Concr is a techbio company focused on enhancing cancer treatment through innovative predictive modeling. Utilizing methods derived from astrophysics, Concr aims to accurately forecast patient outcomes and responses to both novel and existing cancer therapies. The company's cloud-native platform, FarrSight®, enables researchers to simulate clinical trials, predict therapeutic responses, and conduct bioinformatics analyses, facilitating a more personalized approach to cancer care. By leveraging fragmented data from various stages of drug development, Concr eliminates the reliance on big data while generating precise multi-modal tumor models. Headquartered in London, with a subsidiary in Brisbane, Australia, Concr is backed by prominent investors, including the University of Cambridge Enterprise and Oncology Ventures, among others.

Mission Zero develops air capture technology that removes carbon dioxide from the atmosphere and concentrates it for sequestration pathways. The system is designed to recover historic CO2 at any scale by pulling ambient air, dissolving the carbon in a water solvent, and releasing it as a gas through electrodialysis, enabling CO2 users, project developers, engineers, and scientists to convert historic carbon waste into climate value.

Holy Grail develops an air carbon capture device designed to capture carbon dioxide from large centralized emitters and the atmosphere, with the captured CO2 permanently stored above ground. The device uses an electrochemical approach that employs electrons to facilitate carbon capture. The company engages in research and development and engineering of products such as batteries, catalysts, and material datasets that can be used to cross-validate predictions and simulations of experimental data. This technology is positioned to help industrial clients improve energy efficiency and economics by reducing emissions and enabling practical carbon management.

Mytos is a company focused on creating a fully automated cell manufacturing platform tailored for the biotechnology sector, particularly in drug development. The platform utilizes advanced automation technology to streamline the production of human cells, allowing pharmaceutical and biotech companies to optimize their cell culture processes. By enabling scientists to easily modify culturing protocols, Mytos facilitates more rapid advancements in cell growth and overall efficiency in research and development. This innovative approach aims to enhance the capabilities of businesses in the drug development industry by providing a sophisticated solution for cell production.

New Motion Labs (NML) is a mechanical engineering intellectual property licensing company based in the United Kingdom. NML specializes in the development and licensing of innovative sprocket tooth profiles designed for sprocket manufacturers. Their proprietary technology, known as Enduo, transforms traditional chain drive systems by facilitating dual point engagement on both sides of the sprocket tooth. This advancement significantly enhances the longevity of conventional chain drives, allowing them to last up to 3.5 times longer and reducing energy losses by 50%. The new tooth profile leads to decreased wear and friction, resulting in a more efficient drivetrain that can be easily retrofitted to existing applications. Through this technology, NML aims to provide users with lightweight and efficient solutions for power transmission.

Beta Bugs specializes in insect genetics, developing high-performance Black Soldier Fly breeds for insect farmers. Headquartered at Easter Bush Campus, it collaborates with the Roslin Institute to enhance productivity in the insect protein sector.